HospiceChoice Rx is On the Move in 2025
New Company Leadership and NaviScript Launch Fostering Significant Company Growth
HospiceChoice Rx CEO
Opalich also shared that Chief Clinical Officer
Earlier this summer, HospiceChoice Rx launched one of those many benefits the marketplace is responding to, NaviScript. NaviScript is a proprietary ePrescribing software exclusively for hospices that is winning over new clients with its state of the art functionality and ease of use for hospice nursing staff. Company President
Finally, HospiceChoice Rx President
About HospiceChoice Rx
HospiceChoice Rx delivers innovative pharmacy benefits exclusively for Hospice and Palliative Care organizations through its advanced NaviScript platform. NaviScript streamlines clinician ePrescribing, integrates with Hospice EMRs to reduce dual entry, and lessens administrative burden—freeing more time for patient care. With a nationwide network of over 75,000 pharmacies and partnerships with preferred providers, HospiceChoice Rx ensures patients have reliable access to medications wherever they reside. The company also offers expert PharmD clinical consultations to advise on therapeutic alternatives and deprescribing, supporting cost-effective, high-quality patient care. Learn more at www.hospicechoicerx.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/hospicechoice-rx-is-on-the-move-in-2025-302560636.html
SOURCE HospiceChoice Rx
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Dollywood Foundation Honors the Life and Legacy of Dolly Parton
- The SBB Research Group Foundation Sponsors Women United of Lake County
- Solana Price Prediction Turns Bullish Fast as Pepeto Becomes the Presale Smart Wallets Refuse to Miss
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share